ALISO VIEJO, Calif., Feb. 22, 2022 /PRNewswire/ — MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia.  MicroVention received […]